FDA: No Cold, Cough Medicines for Babies
FDA Rules That Over-the-Counter Cough and Cold Medicines Shouldn't Be Given to Kids Younger Than 2
Jan. 17, 2008 -- The FDA today urged parents and caregivers not to give over-the-counter (OTC) cough and cold medicines to children younger than 2 because of dangerous side effects.
"We strongly recommend that over-the-counter cough and cold products should not be used in infants and young children under 2 years of age because serious and potentially life-threatening side effects can occur from use of these products," Charles Ganley, MD, director of the FDA's Office of Nonprescription Products, said at a news conference.
OTC cough and cold products include decongestants, expectorants, antihistamines, and antitussives (cough suppressants) for the treatment of colds.
An FDA news release states that rare, serious adverse events -- including convulsions, rapid heart rates, decreased levels of consciousness, and
-- have been reported with use of cough and cold products.
The FDA is still reviewing the use of cough and cold medicines in children aged 2-11.
Today's FDA recommendation is in line with the findings of an FDA advisory panel that weighed in on the topic last October, shortly after makers of OTC cough and cold drugs for infants voluntarily took those products off the market.
A key concern has been the potential for accidental overdoses if the dosing instructions for those drugs aren't followed exactly as instructed.
"I will point out that the FDA has never endorsed the use of these products in children less than 2 years of age," Ganley says. "We've always acknowledged that there was no safety and efficacy data. It was really left to the discretion of health providers to determine whether use of one of these products was appropriate in these age groups."
Ganley says the FDA decided to issue today's advisory after learning of recent surveys that show that some parents aren't aware of the warnings issued last fall about the use of OTC cough and cold drugs in kids younger than 2.
"This announcement will bring this issue back into the public consciousness, particularly since it's cold season now," Ganley says.
The Consumer Healthcare Products Association (CHPA), a trade group representing makers of over-the-counter (OTC) medicines, issued a statement supporting today's FDA's decision.